Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2008
08/21/2008US20080201792 Transgenic seed for propagation of disease resistant crop plants; biological pest control
08/21/2008US20080201791 T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells
08/21/2008US20080201790 Method and product for regulating cell responsiveness to external signals
08/21/2008US20080201789 Variants and exons of the glyt1 transporter
08/21/2008US20080201788 Rodent animal model having decreased or deleted activity of an enzyme relating to modification of sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine; targeting medicants to 1,6-fucosyltransferase
08/21/2008US20080201787 Transgenic mouse whose genome comprises a homozygous disruption of its alpha1G gene, a method of preparing the same and use thereof
08/21/2008US20080200665 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine
08/21/2008US20080200663 Expression vector comprising nucleotide sequences coding fusion protein comprising HIV preintegration protein Vpr attached to amino or carboxy terminus of the Cre recombinase for use as genetic transfer tool in gene therapeutics
08/21/2008US20080200662 Nucleotide sesequences coding hydroperoxide lyase for use in preserving food flavor and odor
08/21/2008US20080200661 Composition for in vivo delivery
08/21/2008US20080200659 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
08/21/2008US20080200652 Immunoglobulin fusion for use as diagnostic sensor and drug screening tool
08/21/2008US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
08/21/2008US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
08/21/2008US20080200419 Deletion and frame shift mutation; protecting hematopoietic stem cells from cytotoxic stress; enhancing maintenance in vitro during retroviral transduction; slowing aging; leukemia, solid tumors, genetic disorders
08/21/2008US20080200417 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
08/21/2008US20080200416 Modulation of T cell signaling threshold and T cell sensitivity to antigens
08/21/2008US20080200415 Plant Activation of Insect Toxin
08/21/2008US20080200414 HCaRG, A Novel Calcium-Regulated Gene
08/21/2008US20080200413 Oligonucleotide sequences which bind biomolecules such as peptides; selectively bind coagulation factors, E2F family members, Ang1 or Ang2; hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals
08/21/2008US20080200412 Astrocyte Elevated Gene-1 And Its Promoter In Treatments For Neurotoxicity And Malignancy
08/21/2008US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder
08/21/2008US20080200409 Binds to and modifies splicing of dystrophin gene; muscular dystrophy
08/21/2008US20080200408 Isolated recombinant nucleic acids; expression constructs; stably transformed or transfected host cells; sodium channel antagonistic analgesic agents; side effect reduction
08/21/2008US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis
08/21/2008US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering
08/21/2008US20080200388 Stem cell factor-like proteins and uses thereof
08/21/2008US20080200378 KGF polypeptide compositions
08/21/2008US20080200369 Inhibiting bystin mediated arrest and promoting autophosphorylation of epidermal growth factor receptor; sperm motility, embryonic stem cell formation, trophoblast formation, neuronal growth
08/21/2008US20080199961 oligonucleotide composed of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit
08/21/2008US20080199960 Methods for the Delivery of Oligomeric Compounds
08/21/2008US20080199952 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity
08/21/2008US20080199942 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
08/21/2008US20080199940 Cosmids; vectors; prokaryotics; Micromonospora biosynthesis
08/21/2008US20080199938 Glucanse comprising substituted amino acids for use in enhancing detergents and improving the touch and/or appearance of cellulose-containing fabric
08/21/2008US20080199936 FEN Endonucleases
08/21/2008US20080199931 Expression vector comprising estrogen signaling protein (IEBP) for use as tool in diagnosis, prevention and treatment of cell proliferative abd bone disorders
08/21/2008US20080199926 Methods and Organisms for Growth-Coupled Production of 3-Hydroxypropionic Acid
08/21/2008US20080199920 From L-lysine
08/21/2008US20080199919 Plasmid comprising lysine biosynthetic enzymes for use in transforming metnaobacterium into bioreactor for syntesis of lysine and arginine to use in medicine, nutraceuticals and animal foodstuffs
08/21/2008US20080199917 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
08/21/2008US20080199915 Methods and Kits For Mass Production Of Dsrna
08/21/2008US20080199906 Optimized Nucleotide Sequences Encoding Sgp 130
08/21/2008US20080199898 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology
08/21/2008US20080199889 Nucleotide sequences coding orphan receptor for use in identifying modulators for prevention and treatment of diabetes
08/21/2008US20080199888 Follicle stimulating hormone receptor for use in identifying modulators for prevention and treatment of osteoporosis, menopausal, prostate cancer and polycystic ovary syndrome (PCOS)
08/21/2008US20080199886 Igf binding proteins
08/21/2008US20080199883 Protein kinase (PAPAP) for use in diagnosis, prevention and treatment of nervous system disorders
08/21/2008US20080199868 Massive parallel method for decoding DNA and RNA
08/21/2008US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics
08/21/2008US20080199864 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses
08/21/2008US20080199856 Probe for Diagnosis of Marfan Syndrome and a Method for Screening Using the Probe
08/21/2008US20080199854 Methods and compositions for identifying RNA-binding proteins
08/21/2008US20080199853 Methods and Compositions for Diagnosis and Monitoring Auto Immune and Chronic Inflammatory Diseases
08/21/2008US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures
08/21/2008US20080199529 Nanoparticle delivery vehicle
08/21/2008US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy
08/21/2008US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides
08/21/2008US20080199493 cytomegalio viruses; herpes virus; maintenance high level of immunology response; therapy or prevention of infections; genetic engineered vector; gene expression of antigen or fusion protein
08/21/2008US20080199481 B cell-attracting chemokine 1 specific immunoglobulin for use in treatment and prevention of rheumatoid arthritis
08/21/2008US20080199479 Method of treating a muscle-related condition with modified IGF1 polypeptides
08/21/2008US20080199475 Novel glycosylated peptide target in neoplastic cells
08/21/2008US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis
08/21/2008US20080199468 Method For Diagnosing Colorectal Cancers
08/21/2008US20080199467 Immunoglobulin supergene fusion for use in treatment of vascular disorders
08/21/2008US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders
08/21/2008US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits
08/21/2008US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders
08/21/2008US20080199443 Bone Morphogenetic Variants, Compositions and Methods of Treatment
08/21/2008US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin
08/21/2008US20080199435 IL-8 Like Protein
08/21/2008US20080199433 Complementing cell lines
08/21/2008US20080199424 Mart-1 t cell receptors
08/21/2008US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
08/21/2008US20080196173 Novel Laccases, Compositions And Methods of Use
08/21/2008DE10251429B4 Ein schnelles Verfahren zum Transformieren kompetenter Zellen A rapid method to transform competent cells
08/21/2008DE102007008596A1 Biologisch wirksame Moleküle, insbesondere auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung Biologically active molecules, in particular on the basis of PNA and siRNA, methods for their cell-specific activation and application kit for administering
08/21/2008CA2678436A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/21/2008CA2678044A1 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered
08/21/2008CA2678013A1 Lung cancer-targeted peptides and applications thereof
08/21/2008CA2677911A1 Method of detecting equine polysaccharide storage myopathy
08/21/2008CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same
08/21/2008CA2677748A1 Binding members for ige molecules
08/21/2008CA2677568A1 A recombinant host cell for the production of a compound of interest
08/21/2008CA2677469A1 Truncated alternan sucrase coding nucleic acid molecules
08/21/2008CA2677171A1 Transfection in magnetically driven continuous flow
08/21/2008CA2676157A1 Plants with altered root architecture, involving the rum1 gene, related constructs and methods
08/21/2008CA2675926A1 Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
08/21/2008CA2671203A1 Improved grg23 epsp synthases: compositions and methods of use
08/21/2008CA2664791A1 Recombinant rhinovirus vectors
08/21/2008CA2579588A1 Assessment of risk for colorectal cancer
08/21/2008CA2578493A1 A role for sry in parkinson's disease
08/20/2008EP1959255A2 Closed-loop biochemical analyzers
08/20/2008EP1959022A1 Detection of uterine leiomyosarcoma using lmp2
08/20/2008EP1959020A1 Process for production of ceramide using transformed yeast
08/20/2008EP1959018A1 Optimizing glycan processing in plants
08/20/2008EP1959017A1 Methods for the production of insulin in plants
08/20/2008EP1959016A2 Plant amino acid biosynthetic enzymes
08/20/2008EP1959015A2 Secreted streptococcus pneumoniae proteins
08/20/2008EP1959014A2 Antibodies against insulin-like growth factor I receptor and uses thereof